Every Form 4 that Astronics (ATRO) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ATRO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ATRO filings page.
ASTRONICS CORP (ATRO) director Robert S. Keane reported an internal share reclassification on August 25, 2026. Boston & Saranac LLC, an entity indirectly associated with him, converted 76,000 Class B shares into 76,000 shares of $.01 par value common stock, all held indirectly. Keane also reports direct holdings of 13,934 common shares and 2,786 Class B shares, plus an additional indirect Class B position held in a trust where he is one of multiple beneficiaries with a proportionate interest below 25%.
Astronics Corp (ATRO) reported that Executive VP & President–Aerospace Mark Peabody made a bona fide gift of 150 shares of $.01 par value common stock on 2026-08-18, leaving him with 62,232.73 common shares held directly. He also directly holds 232,610 Class B shares and multiple stock options on both common and Class B stock at exercise prices between $8.12 and $29.68 per share. In addition, he holds several performance-based restricted stock unit awards, including 15,900, 15,150 and 7,675 common-stock RSUs (and corresponding Class B RSUs) that may vest between 50% and 150% of target based on Astronics’ average annual adjusted EBITDA over three-year periods ending in 2026, 2027 and 2028.
ASTRONICS CORP (ATRO) director Jeffry D. Frisby reported a bona fide gift of 2,000 shares of $.01 par value common stock on 2026-08-17, leaving him with 45,056 common shares held directly. He also holds 9,411 shares of $.01 par value Class B stock directly as of the same date.
In addition, Frisby continues to hold several option awards directly, including options over 4,000 common shares at $23.75 and 4,000 common shares at $28.37, plus options over 1,520 Class B shares at each of those exercise prices, with expirations in 2027 and 2028.
Astronics Corp executive Mark Peabody reported updated equity holdings, mainly reflecting a new Class B stock distribution and performance-based awards. The filing shows he now directly holds 62,382.73 shares of common stock and 232,610 shares of Class B stock as of June 15, 2026.
The Class B position increased by 49,165 shares issued through a one-for-five distribution of Class B stock to holders of both common and Class B stock on the June 15, 2026 record date. Peabody also holds multiple restricted stock unit and option awards tied to Astronics’ common and Class B stock, several of which vest based on average annual adjusted EBITDA performance for 2024–2026, 2025–2027, and 2026–2028, with potential vesting between 50% and 150% of target on specified dates in 2027, 2028, and 2029.
Astronics Corp director Neil Y. Kim reported internal equity adjustments rather than market trades. The filing shows a one-for-five distribution of Class B stock, issuing 8,811 Class B shares to him. Related option positions on Class B stock totaling 1,840 underlying shares were also adjusted, while he continues to hold 44,056 common shares and existing options on common stock.
Astronics Corp director Warren C. Johnson reported administrative equity updates related to a Class B stock distribution. On June 15, 2026, he reported holding 49,756 shares of $.01 par value common stock and 9,951 shares of $.01 par value Class B stock. The filing notes that the Class B shares were issued pursuant to a one-for-five distribution of Class B stock to holders of both common and Class B stock as of the record date June 15, 2026, at a stated price of $0.0000 per share.
Johnson also reported stock options on common stock covering 4,000 underlying shares at an exercise price of $28.37 per share expiring on March 2, 2028, and options covering another 4,000 underlying common shares at an exercise price of $23.75 per share expiring on March 7, 2027. Additional option entries with transaction code J reflect other acquisitions or dispositions tied to 920 underlying Class B shares at each exercise price. The transactions do not reflect any open-market purchases or sales.
Astronics Corp director Robert S. Keane reported internal reallocations of Class B stock, not market trades. The Form 4 shows a holding entry for 13,934 shares of common stock held directly and several “J” code transactions, classified as other acquisitions or dispositions.
The filing reflects 2,786 Class B shares held directly after these transactions, plus large indirect Class B positions held through entities described as an LLC and a trust. A footnote states the shares were issued via a one-for-five distribution of Class B stock to holders of both Common and Class B stock on the record date of June 15, 2026, indicating a stock distribution and ownership-structure updates rather than open-market buying or selling.
Astronics Corp director Mark J. Moran reported updated holdings in the company’s stock. He received 8,811 shares of $.01 par value Class B stock at a stated price of $0.0000 per share, described as an “other transaction.” The footnote explains these shares were issued pursuant to a one-for-five distribution of Class B stock to holders of both Common and Class B stock on the record date of June 15, 2026. Following this, he directly holds 44,056 shares of $.01 par value Common Stock and 8,811 shares of Class B stock.
Astronics Corp Secretary Julie M. Davis reported changes in her equity holdings tied to a one-for-five distribution of Class B stock and related equity awards. She now holds 2,256 shares of Class B stock directly after receiving 1,620 shares in the distribution.
Davis also reports 7,466.251 shares of common stock held directly, plus several blocks of restricted stock units (RSUs) over common stock totaling 1,916, 4,500 and 2,500 underlying shares, along with an option over 1,500 common shares at an exercise price of $26.47 expiring on December 14, 2026.
Certain RSUs are time-based and scheduled to vest 100% on February 22, 2027 and February 27, 2028. Another RSU grant is performance-based, vesting between 50% and 150% of its target amount on February 19, 2029, depending on Astronics Corp's average annual adjusted EBITDA for the period January 1, 2026 through December 31, 2028.
Astronics Corp principal accounting officer Nancy L. Hedges reported restructuring-type equity movements and updated her holdings. She now directly holds 32,048.975 shares of common stock and 7,953 shares of Class B stock, reflecting a one-for-five distribution of 6,666 Class B shares to holders as of June 15, 2026.
Hedges also holds multiple restricted stock unit (RSU) awards. RSUs tied to common stock cover 12,150, 17,700 and 5,024 underlying shares. Additional RSUs tied to Class B stock cover 2,430, 3,540 and 1,004 underlying shares. These RSUs vest based on Astronics’ average annual adjusted EBITDA for performance periods running from 2024–2026, 2025–2027 and 2026–2028, with 50% to 150% of target units potentially vesting on settlement dates in 2027, 2028 and 2029.
Astronics Corp director Fay West reported updated share holdings. The Form 4 shows ownership of 7,588 shares of $.01 par value common stock and 1,517 shares of $.01 par value Class B stock held directly.
The 1,517 Class B shares were issued pursuant to a one-for-five distribution of Class B stock to holders of both common and Class B stock as of the record date of June 15, 2026. This reflects a stock distribution rather than an open-market trade.
Astronics Corp director Jeffry D. Frisby reported administrative equity changes tied to a stock distribution, not an open-market trade. The entry shows he directly holds 47,056 shares of $.01 par value common stock and 9,411 shares of $.01 par value Class B stock after the reported transactions.
Code J entries reflect “other” transactions, including 9,411 Class B shares issued at a stated price of $0.00 per share and related option adjustments. A footnote explains these shares were issued through a one-for-five distribution of Class B stock to holders of both Common and Class B stock as of the June 15, 2026 record date.
Astronics Corp President and CEO Peter J. Gundermann reported internal equity restructurings rather than open-market trades. A key entry shows 168,375 shares of $.01 par value Class B stock issued in connection with a one-for-five distribution to holders of both common and Class B stock as of a June 15, 2026 record date.
The filing also details his direct holdings of 93,967.608 shares of $.01 par value common stock, plus a range of stock options and restricted stock units tied to common and Class B shares. These equity awards include performance-based RSUs whose vesting depends on Astronics Corp.'s average annual adjusted EBITDA over multi‑year periods through 2028, with 50% to 150% of target units potentially vesting on scheduled dates in 2027, 2028, and 2029.
Astronics Corp director Linda O'Brien reported changes in how she and her spouse hold company stock, driven by a one-for-five distribution of Class B stock to holders of both Common and Class B shares as of the record date of June 15, 2026.
Following these non-market transactions, she holds 21,372 shares of $.01 par value Common Stock directly and 1,200 Common shares indirectly through her husband. She also holds 4,274 shares of $.01 par value Class B Stock directly and 240 Class B shares indirectly, all reported at a transaction price of $0.00 per share.
Astronics Corp executive James Mulato reported updated equity holdings in common and Class B shares, restricted stock units, and options as of June 15, 2026. The filing shows 7,645 shares of Class B stock involved in transactions coded “J” (other acquisition or disposition), with 10,098 Class B shares held directly afterward.
The report also lists ongoing incentive awards, including performance-based restricted stock units tied to Astronics’ average annual adjusted EBITDA for 2024–2026, 2025–2027, and 2026–2028, where 50%–150% of target units may vest in early 2027, 2028, and 2029 based on actual performance. No open‑market purchases or sales are reported in this filing.
Astronics Corp director Robert T. Brady reported a stock distribution and updated holdings. He received 53,085 shares of $.01 par value Class B stock at a stated price of $0.0000 per share, issued pursuant to a one-for-five distribution of Class B stock to holders of both Common and Class B shares as of the June 15, 2026 record date.
Following this non‑market restructuring transaction, he directly holds 229,451 shares of Class B stock and 89,063 shares of $.01 par value common stock$28.37 and $23.75 per share with expirations in 2028 and 2027.
Astronics Corp officer Julie M. Davis, Secretary, exercised 3,000 restricted stock units into common stock at $81.35 per share on March 3, 2026. 1,472 shares of common stock were withheld by Astronics Corp to satisfy tax withholding upon vesting.
After these transactions, she directly held 7,466.251 shares of common stock, multiple tranches of restricted stock units totaling 2,500, 4,500, and 1,916 units, and 636 shares of Class B stock. Some RSUs vest 50–150% of target based on average annual adjusted EBITDA for periods ending in 2026 and 2027, with vesting dates in 2027, 2028, and 2029.
Astronics Corp executive Mark Peabody, Executive VP & President – Aerospace, exercised 10,850 restricted stock units on March 3, 2026, converting them into an equal number of shares of $.01 par value common stock at a transaction price of $81.35 per share.
2,642 common shares were disposed of in a code F transaction, with shares withheld by Astronics Corp to satisfy applicable withholding tax upon vesting of restricted stock units, leaving 62,382.73 common shares held directly after these transactions. Footnotes describe multiple restricted stock unit awards that depend on Astronics Corp.'s average annual adjusted EBITDA over performance periods from January 1, 2023 - December 31, 2028, where between 50% and 150% of the target number of units may vest on specified dates in 2027, 2028, and 2029, with one award reflecting 100% of the target number of units that vested on February 23, 2026.
Astronics Corp Principal Accounting Officer Nancy L. Hedges exercised 5,050 restricted stock units on March 3, 2026, receiving 5,050 shares of $.01 par value common stock at a transaction price of $81.35 per share. A related derivative security entry shows 5,050 restricted stock units exercised or converted, leaving 0 such units from that award.
To cover withholding taxes upon this vesting, 1,821 common shares were disposed of at $81.35 per share through a tax-withholding transaction, leaving Hedges with 32,048.975 common shares held directly as of that date. Footnotes state these restricted stock units vested 100% on February 23, 2026.
Hedges also holds several performance-based restricted stock unit awards. One award’s vesting depends on Astronics Corp.’s average annual adjusted EBITDA for January 1, 2024–December 31, 2026, with 50%–150% of the target units potentially vesting on February 22, 2027 based on actual performance. A second award is tied to average annual adjusted EBITDA for January 1, 2025–December 31, 2027, with 50%–150% of target units potentially vesting on February 27, 2028. A third award depends on average annual adjusted EBITDA for January 1, 2026–December 31, 2028, with 50%–150% of target units potentially vesting on February 19, 2029. Each restricted stock unit represents the right to receive one share of common stock at settlement.
Astronics Corp executive James Mulato reported equity award activity. On March 3, 2026, he exercised 11,500 restricted stock units, converting them into 11,500 shares of $.01 par value common stock at $81.35 per share, and held these shares directly.
Astronics Corp withheld 2,801 common shares at $81.35 per share to satisfy applicable withholding tax upon vesting of restricted stock units, leaving Mulato with 35,776.822 directly owned common shares as of that date. Each restricted stock unit represents the right to receive one share of common stock at settlement.
The filing also describes performance-based restricted stock units whose vesting depends on Astronics Corp's average annual adjusted EBITDA for periods spanning 2023–2028. Between 50% and 150% of target units may vest on February 23, 2026, February 22, 2027, February 27, 2028, and February 19, 2029, with vesting percentages determined based on actual performance.
Astronics Corp President and CEO Peter J. Gundermann reported equity award activity. On March 3, 2026, he exercised 13,550 restricted stock units, receiving the same number of $.01 par value common shares at a stated price of $81.35 per share, and ended with 93,967.608 common shares held directly. To cover withholding taxes, 3,489 common shares were withheld by Astronics Corp.
Footnotes explain that each restricted stock unit converts into one common share at settlement. Several performance-based restricted stock unit awards depend on Astronics Corp.'s average annual adjusted EBITDA for periods spanning 2023–2028; between 50% and 150% of target units may vest on February 23, 2027, February 27, 2028, and February 19, 2029, based on actual performance. One grant covering the 2023–2025 period vested at 100% of the target on February 23, 2026.
Astronics Corp director Robert T. Brady reported several equity award transactions. On February 26, 2026, he exercised stock options for 4,000 options and another 1,290 options, receiving common and Class B shares of Astronics as noted in the footnotes as shares acquired upon exercise of stock options.
Following these exercises, his direct holdings increased to 89,063 shares of $.01 par value common stock and 176,366 shares of $.01 par value Class B stock. In a separate transaction coded “F”, 1,539 common shares were withheld by Astronics Corp to cover the option exercise price or related tax obligations, rather than being sold on the open market.
GUNDERMANN PETER J reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corp President and CEO Peter J. Gundermann received a grant of 12,150 restricted stock units on February 19, 2026. Each unit represents the right to receive one share of common stock at settlement.
The vesting of this award depends on Astronics Corp.'s average annual adjusted EBITDA for the period from January 1, 2023 through December 31, 2025. Between 75% and 115% of the target 12,150 units may vest on February 23, 2026, with the final vesting percentage determined by actual performance over that period.
Astronics Corporation director Robert T. Brady acquired 1,533 shares of $.01 par value common stock on a grant/award basis on February 19, 2026. The stock bonus was compensation for his service as a director and increased his directly held common shares to 86,602. As of the same date, he also directly held 175,076 shares of $.01 par value Class B stock and several blocks of stock options with reported remaining option balances.
Astronics Corporation director Neil Y. Kim reported an equity award. On February 19, 2026, he acquired 1,533 shares of $.01 par value common stock as a stock bonus award for his service as a director. After this grant, he directly holds 44,056 common shares.
Keane Robert S reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corporation director Robert S. Keane received a stock bonus of 1,533 shares of $.01 par value common stock on February 19, 2026 as compensation for board service, at a stated price of $0.0000 per share.
After this grant, his directly held common stock position increased to 13,934 shares. The filing also reports indirect holdings of $.01 par value Class B stock, including 206,886 shares held through a trust for multiple potential beneficiaries and 208,199 shares held through Boston & Saranac LLC, which is owned by a trust whose beneficiaries include Keane and his spouse.
JOHNSON WARREN C reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corporation director Warren C. Johnson received a stock bonus award of 1,533 shares of $.01 par value common stock on 2026-02-19. The shares were granted as compensation for his service as a director, at a reported price of $0.00 per share.
After this award, Johnson directly owns 49,756 common shares and continues to hold multiple option positions in Astronics stock.
O'Brien Linda reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corp director Linda O'Brien received a stock bonus award of 1,533 shares of $.01 par value common stock as compensation for her service as a director. The award was recorded at a price of $0.00 per share and increased her directly owned holdings to 21,372 shares.
The filing also notes 1,200 shares held indirectly through her spouse, reflecting additional ownership associated with her household.
PEABODY MARK reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corp Executive VP & President of Aerospace Mark Peabody reported an award of 7,675 restricted stock units on February 19, 2026. Each unit represents the right to receive one share of common stock. Vesting depends on Astronics’ average annual adjusted EBITDA for 2026–2028, with 50% to 150% of the target units potentially vesting on February 19, 2029 based on actual performance.
Astronics Corp reported that Principal Accounting Officer Nancy L. Hedges acquired 12,150 restricted stock units on February 19, 2026 as a grant or award. Each unit represents one share of common stock at settlement. The award is performance-based, with vesting tied to Astronics’ average annual adjusted EBITDA for the period from January 1, 2026 to December 31, 2028. Between 50% and 150% of the target number of units may vest on February 19, 2029, depending on actual performance.
West Fay reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corporation director Fay West received a stock bonus award of 1,533 shares of $.01 par value common stock as compensation for service as a director. The shares were awarded on February 19, 2026 at no stated purchase price, increasing West’s directly owned holdings to 7,588 shares.
FRISBY JEFFRY D reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corp director Jeffry D. Frisby received a stock bonus award of 1,533 common shares on February 19, 2026 as compensation for his board service. After this grant, he directly owns 47,056 Astronics common shares, reflecting equity-based compensation rather than an open-market share purchase.
MORAN MARK J reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corporation director Mark J. Moran received a stock bonus award of 1,533 shares of $.01 par value common stock as compensation for his board service. The award was granted at no cash cost and increases his directly owned stake to 44,056 shares.
Mulato James reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corp reported that James Mulato, President of Astronics Test Systems, received a grant of 7,675 restricted stock units on February 19, 2026 at no cash cost. Each unit represents the right to receive one share of common stock at settlement.
The filing explains that vesting of these restricted stock units depends on Astronics Corp's average annual adjusted EBITDA over specified multi‑year periods. Between 50% and 150% of the applicable target unit amounts may vest on future February dates, with the actual vesting percentage determined by the company’s performance.
PEABODY MARK reported disposition transactions in a Form 4 filing for ATRO. The filing lists transactions totaling 2,500 shares. Following the reported transactions, holdings were 183,445 shares.
Astronics Corp insider Peter J. Gundermann, the company’s President, CEO and a director, reported a new grant of 29,750 stock options on December 4, 2025. The options have an exercise price of $51.72 per share, become exercisable on December 4, 2026, and expire on December 4, 2035, and relate to $.01 par value common stock.
After the reported transaction, he directly owned 83,906.608 shares of $.01 par value common stock and 747,911 shares of $.01 par value Class B stock. The filing also lists multiple existing option grants and restricted stock units, each RSU representing the right to receive one share of common stock at settlement. Several RSU awards for 9,206, 26,450 and 25,250 shares may vest in 2026, 2027 and 2028 based on Astronics’ average annual adjusted EBITDA over the periods January 1, 2023–December 31, 2025, January 1, 2024–December 31, 2026, and January 1, 2025–December 31, 2027, with vesting ranges between 75% and 115% or between 50% and 150% of target depending on the grant.
Astronics Corp executive James Mulato, President of Astronics Test Systems, reported a stock transaction and updated his equity holdings. On 12/01/2025, he sold 9,734 shares of $.01 par value common stock at $53.24 per share. After this sale, he directly holds 27,077.822 shares of common stock and 2,453 shares of Class B stock.
He also reports a broad set of stock options on Astronics common and Class B stock, with exercise prices ranging from $9.74 to $35.61 and expiration dates from 2026 through 2033. In addition, he holds performance-based restricted stock units (RSUs): 18,550 units tied to average annual adjusted EBITDA for 2024–2026 that may vest between 50% and 150% of target on February 22, 2027; 11,500 units tied to EBITDA for 2023–2025 that may vest between 75% and 115% on February 23, 2026; and 17,700 units tied to EBITDA for 2025–2027 that may vest between 50% and 150% on February 27, 2028, all based on actual performance.
Astronics Corp (ATRO) reported insider equity activity by its President and CEO, who is also a director. On 11/20/2025, he exercised stock options for 13,700 shares of $.01 par value common stock and 4,418 shares of $.01 par value Class B stock at an exercise price of $27.72 per share. To cover withholding taxes from the option exercise, 11,707 common shares were withheld at a price of $49.35 per share. Following these transactions, he beneficially owned 83,906.608 shares of common stock and 747,911 shares of Class B stock directly. The filing also lists multiple remaining stock option grants and restricted stock units that vest over future years based on Astronics’ average annual adjusted EBITDA performance metrics, with potential vesting between 50% and 150% of target. This Form 4 clarifies that these transactions are being reported on an original filing rather than an amendment.
Astronics Corp. (ATRO) President and CEO Peter J. Gundermann reported multiple equity transactions dated 11/20/2025. He exercised stock options to acquire 13,700 shares of $.01 par value common stock and 4,418 shares of $.01 par value Class B stock at an exercise price of $27.72 per share. To cover withholding taxes tied to the option exercise, 11,707 common shares were withheld at a price of $49.35 per share. Following these transactions, he directly owned 83,906.608 common shares and 747,911 Class B shares.
The filing also lists outstanding equity awards. These include multiple stock option grants with exercise prices ranging from $9.74 to $35.61 per share and expirations between 12/03/2025 and 12/07/2033, as well as several restricted stock unit awards tied to Astronics’ average annual adjusted EBITDA performance for periods running from 2023–2027, with potential vesting ranges between 50% and 150% of target on future dates.
Astronics Corp (ATRO) Executive VP & President–Aerospace Mark Peabody reported exercising stock options and acquiring company shares. On 11/19/2025, he exercised options to acquire 4,500 shares of $.01 par value common stock at $27.72 per share and 1,451 shares of $.01 par value Class B stock at $27.72 per share. Following these transactions, he beneficially owned 55,324.73 common shares and 185,445 Class B shares directly.
The filing also lists multiple option grants and restricted stock units. Several RSU awards vest based on Astronics’ average annual adjusted EBITDA over multi‑year periods ending December 31, 2025, December 31, 2026, and December 31, 2027, with between 50% and 150% (or 75% to 115% for one grant) of target units eligible to vest in February 2026, February 2027, and February 2028 based on actual performance.
Astronics Corp (ATRO) officer and Principal Accounting Officer Nancy L. Hedges reported multiple equity transactions. On 11/17/2025, she exercised stock options for a total of 3,600 shares of common and Class B stock at exercise prices of $27.72 and $31.76. Some of the resulting common shares were withheld by Astronics to cover tax obligations at a price of $52.15.
After these transactions, she continued to hold Astronics common and Class B shares directly, as well as several blocks of restricted stock units (RSUs). These include 17,700, 5,024, and 5,050 RSUs, each representing the right to receive one share of common stock at settlement. Two RSU awards vest between 50% and 150% of a target amount based on Astronics’ average annual adjusted EBITDA over performance periods running through December 31, 2026 and December 31, 2027, with potential vesting on February 22, 2027 and February 27, 2028. Another RSU grant is scheduled to vest February 23, 2026.
Astronics Corp (ATRO) disclosed an insider equity transaction on a Form 4. Officer James Mulato (President, Astronics Test Systems) exercised stock options on 10/22/2025, acquiring 4,300 shares of $.01 par value Common Stock and 1,387 shares of $.01 par value Class B Stock at an exercise price of $27.72 per share.
Following these transactions, Mulato beneficially owned 36,811.822 shares of Common Stock and 2,453 shares of Class B Stock, held directly. The filing shows multiple remaining option grants with various exercise prices and expirations, as well as performance-based RSUs. Footnotes state that RSUs vest based on average annual adjusted EBITDA over specified multi-year periods, with vesting on stated dates tied to performance outcomes.
Mark Peabody, Executive Vice President & President-Aerospace of Astronics Corp. (ATRO), reported an acquisition of 1,280 common shares on 09/30/2025 via the Employee Stock Purchase Plan at a reported price of $16.60. After the transaction the filing shows beneficial ownership figures including 50,824.73 (reported in the form) and 183,994 Class B shares.
The filing lists a portfolio of outstanding long-term equity awards: multiple stock options exercisable through 2033 and several restricted stock unit awards that vest based on Astronics’ average annual adjusted EBITDA over specified multi-year performance periods (2023–2025, 2024–2026, 2025–2027) with stated vesting ranges. The Form 4 was signed by a Power of Attorney on 08/28/2025.
James Mulato, President of Astronics Test Systems and a reporting person for Astronics Corporation (ATRO), acquired 1,280 common shares on 09/30/2025 by exercising an Employee Stock Purchase Plan subscription, increasing his beneficial ownership to 32,511.822 shares of common stock and 1,066 shares of Class B stock. The filing lists multiple outstanding stock options with exercise prices from $9.74 to $35.61 and expiration dates through 12/07/2033, and several performance-based restricted stock unit awards whose vesting depends on average annual adjusted EBITDA for specified multi-year periods. The Form 4 was signed on behalf of Mr. Mulato by a power of attorney on 10/02/2025.
Nancy L. Hedges, identified as an officer (Principal Accounting Officer) and director of Astronics Corp (ATRO), reported insider transactions on 09/30/2025. The filing discloses an acquisition of 1,280 common shares through exercise of a subscription agreement under the company’s Employee Stock Purchase Plan. The Form 4 also lists existing derivative and equity holdings: outstanding stock options exercisable through 2025–2026, and several restricted stock unit (RSU) awards totaling 27,948.975 shares reported following the transactions. Some RSUs vest based on performance tied to average annual adjusted EBITDA over specified multi‑year periods, with vesting windows in 2026, 2027, and 2028.
The filing was signed by an attorney-in-fact on behalf of Ms. Hedges on 10/02/2025. Explanations clarify that each RSU equals one share at settlement and that performance‑based RSUs may vest between 50% and 150% of target depending on actual results.